Amitriptyline for irritable bowel syndrome

Ordinarily used to treat other conditions, this trycylic antidepressant performed well in a recent trial on people with IBS. Irritable bowel syndrome (IBS) is estimated...

Protecting your over 60s from the flu

Get ready to help to protect vulnerable Australians over the age of 60 years from influenza and its most deadly complications.

Communicating safely

Instilling quality and safety into conversations around the provision of Pharmacist Only medicines. Effective provision of Pharmacist Only medicines requires a thorough understanding of a...

Long-acting treatment for opioid dependence approved

The first long-acting treatment for opioid dependence has been approved for use in Australia by the Therapeutic Goods Administration (TGA). Buvidal Weekly and Buvidal Monthly...

Exenatide for alcohol use disorder

A better understanding of exenatide can help increase our knowledge of GLP-1 analogues and their possible role in treating addiction.

Preparing for the 2024 ‘tripledemic’

Now is the time to arm Australians with vaccines, respiratory disease advice, testing and essential medicines to get ahead of respiratory ailment season. The trifecta...